Companies / Immunic, Inc.
Immunic, Inc.
Nasdaq: IMUXForeign · IFRSCIK 1280776NEW YORK
Financials
Ownership
13.6M shares outstanding · as of Jul 31, 2026
Ownership
| 10%+ / strategic | 199.33% | 27,197,941 |
| Institutions | 326.51% | 44,550,333 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 23
View all →| Insider | % of shares | Shares |
|---|---|---|
Biotechnology Value Fund II LPDirector | — | — |
Biotechnology Value Fund L PDirector | — | — |
| — | — | |
Bonney Michael WDirector | — | — |
Bvf Gp Holdings LLCDirector | — | — |
Bvf I Gp LLCDirector | — | — |
Bvf II Gp LLCDirector | — | — |
Bvf INC/ILDirector | — | — |
Bvf Partners L P/ILDirector | — | — |
BVF Partners OS Ltd.Director | — | — |
Institutional holders 66
View all →| Holder | Value | % of shares |
|---|---|---|
| $8.49M | 56.09% | |
| $4.40M | 60.42% | |
| $4.31M | 28.45% | |
| $4.20M | 27.70% | |
| $2.68M | 36.79% | |
| $2.51M | 34.44% | |
| $2.34M | 32.09% | |
| $2.29M | 19.22% | |
| $2.04M | 0.97% | |
| $1.69M | 11.18% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Congleton Jon Director | Grant | Stock Option | — | +51K | 50,740 0.37% of shares | low |
| Jun 29, 2026 | Skerjanec Simona Director | Grant | Stock Option | — | +25K | 25,370 0.19% of shares | low |
| Jun 29, 2026 | Rudick Richard Alan Director | Grant | Stock Option | — | +25K | 25,370 0.19% of shares | low |
| Jun 29, 2026 | Neermann Joerg Director | Grant | Stock Option | — | +25K | 25,370 0.19% of shares | low |
| Jun 29, 2026 | Tardio Jason Executive | Grant | Stock Option | — | +253K | 253,000 1.85% of shares | low |
| Jun 29, 2026 | Whaley Glenn Executive | Grant | Stock Option | — | +120K | 120,000 0.88% of shares | low |
| Jun 29, 2026 | Vitt Daniel Director | Grant | Stock Option | — | +445K | 445,000 3.26% of shares | low |
| May 22, 2026 | Lundgren Erik CEO | Grant | Stock Option | — | +1.0M | 1,000,000 7.33% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Aberdeen Group plc | Passive13G/A | — |
| Nantahala Capital Management, LLC | Passive13G/A | — |
| 683 Capital Management, LLC | Passive13G/A | — |
| Alyeska Investment Group, L.P. | Passive13G/A | — |
| Soleus Capital Master Fund, L.P. | Passive13G | — |
| Vivo Opportunity Fund Holdings, L.P. | Passive13G | — |
| Trails Edge Capital Partners, LP | Passive13G | — |
| Commodore Capital LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| IMUX | — | 4525EP101 |
| IMUX | — | 4525EP200 |